Global PCR-based Mycoplasma Testing Service Supply, Demand and Key Producers, 2026-2032

July 2026 | 131 pages | ID: G14A96FA9520EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global PCR-based Mycoplasma Testing Service market size is expected to reach $ 936 million by 2032, rising at a market growth of 4.2% CAGR during the forecast period (2026-2032).

PCR-based Mycoplasma Testing Service refers to outsourced laboratory testing services that use PCR, qPCR, or RT-PCR technologies to detect mycoplasma contamination in cell cultures, biologics, vaccines, viral vectors, cell therapy products, raw materials, and research samples. The service provides rapid, sensitive, and specific detection by amplifying mycoplasma DNA or RNA targets. Compared with traditional culture-based methods, PCR-based testing offers shorter turnaround time, higher sensitivity, and better suitability for biopharmaceutical quality control, cell bank release testing, GMP production monitoring, and contamination investigation. The industrial chain of PCR-based Mycoplasma Testing Service includes upstream PCR reagents, primers, probes, nucleic acid extraction kits, enzymes, controls, sample tubes, PCR instruments, qPCR systems, laboratory consumables, cleanroom facilities, and quality management systems. The midstream includes sample receipt, nucleic acid extraction, PCR amplification, assay validation, contamination control, result interpretation, report generation, data review, and regulatory documentation. Downstream applications include biopharmaceutical companies, vaccine manufacturers, cell and gene therapy developers, contract manufacturing organizations, cell banks, research institutes, diagnostic laboratories, and academic laboratories. Related services include method validation, GMP testing, rapid release testing, deviation investigation, contamination source analysis, and technical consulting.

This report studies the global PCR-based Mycoplasma Testing Service demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for PCR-based Mycoplasma Testing Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of PCR-based Mycoplasma Testing Service that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global PCR-based Mycoplasma Testing Service total market, 2021-2032, (USD Million)
Global PCR-based Mycoplasma Testing Service total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: PCR-based Mycoplasma Testing Service total market, key domestic companies, and share, (USD Million)
Global PCR-based Mycoplasma Testing Service revenue by player, revenue and market share 2021-2026, (USD Million)
Global PCR-based Mycoplasma Testing Service total market by Type, CAGR, 2021-2032, (USD Million)
Global PCR-based Mycoplasma Testing Service total market by Application, CAGR, 2021-2032, (USD Million)

This report profiles major players in the global PCR-based Mycoplasma Testing Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Charles River Laboratories International, Thermo Fisher Scientific, SGS, Bionique Testing Laboratories, WuXi AppTec, Labcorp, IDEXX BioAnalytics, WiCell, Creative Biogene, Eurofins Scientific, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world PCR-based Mycoplasma Testing Service market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global PCR-based Mycoplasma Testing Service Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global PCR-based Mycoplasma Testing Service Market, Segmentation by Type:
  • Product Release Testing
  • Contamination Investigation Testing
  • Regulatory Compliance Testing
  • Others
Global PCR-based Mycoplasma Testing Service Market, Segmentation by Sample Type:
  • Cell Bank Testing
  • Cell Culture Testing
  • Others
Global PCR-based Mycoplasma Testing Service Market, Segmentation by Application:
  • Biopharmaceutical Companies
  • Contract Research/Manufacturing Organizations (CROs/CMOs)
  • Universities and Research Institutions
  • Others
Companies Profiled:
  • Charles River Laboratories International
  • Thermo Fisher Scientific
  • SGS
  • Bionique Testing Laboratories
  • WuXi AppTec
  • Labcorp
  • IDEXX BioAnalytics
  • WiCell
  • Creative Biogene
  • Eurofins Scientific
  • Hylabs
  • JOINN Laboratories
  • Shimadzu Diagnostics
  • CellSafe
  • FullHope Biomedical
  • Syngene International
  • Beyotime
  • CTI Cert
  • Shenke Bio
Key Questions Answered
1. How big is the global PCR-based Mycoplasma Testing Service market?
2. What is the demand of the global PCR-based Mycoplasma Testing Service market?
3. What is the year over year growth of the global PCR-based Mycoplasma Testing Service market?
4. What is the total value of the global PCR-based Mycoplasma Testing Service market?
5. Who are the Major Players in the global PCR-based Mycoplasma Testing Service market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 PCR-based Mycoplasma Testing Service Introduction
1.2 World PCR-based Mycoplasma Testing Service Market Size & Forecast (2021 & 2025 & 2032)
1.3 World PCR-based Mycoplasma Testing Service Total Market by Region (by Headquarter Location)
  1.3.1 World PCR-based Mycoplasma Testing Service Market Size by Region (2021-2032), (by Headquarter Location)
  1.3.2 United States Based Company PCR-based Mycoplasma Testing Service Revenue (2021-2032)
  1.3.3 China Based Company PCR-based Mycoplasma Testing Service Revenue (2021-2032)
  1.3.4 Europe Based Company PCR-based Mycoplasma Testing Service Revenue (2021-2032)
  1.3.5 Japan Based Company PCR-based Mycoplasma Testing Service Revenue (2021-2032)
  1.3.6 South Korea Based Company PCR-based Mycoplasma Testing Service Revenue (2021-2032)
  1.3.7 ASEAN Based Company PCR-based Mycoplasma Testing Service Revenue (2021-2032)
  1.3.8 India Based Company PCR-based Mycoplasma Testing Service Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
  1.4.1 PCR-based Mycoplasma Testing Service Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Major Market Trends

2 DEMAND SUMMARY

2.1 World PCR-based Mycoplasma Testing Service Consumption Value (2021-2032)
2.2 World PCR-based Mycoplasma Testing Service Consumption Value by Region
  2.2.1 World PCR-based Mycoplasma Testing Service Consumption Value by Region (2021-2026)
  2.2.2 World PCR-based Mycoplasma Testing Service Consumption Value Forecast by Region (2027-2032)
2.3 United States PCR-based Mycoplasma Testing Service Consumption Value (2021-2032)
2.4 China PCR-based Mycoplasma Testing Service Consumption Value (2021-2032)
2.5 Europe PCR-based Mycoplasma Testing Service Consumption Value (2021-2032)
2.6 Japan PCR-based Mycoplasma Testing Service Consumption Value (2021-2032)
2.7 South Korea PCR-based Mycoplasma Testing Service Consumption Value (2021-2032)
2.8 ASEAN PCR-based Mycoplasma Testing Service Consumption Value (2021-2032)
2.9 India PCR-based Mycoplasma Testing Service Consumption Value (2021-2032)

3 WORLD PCR-BASED MYCOPLASMA TESTING SERVICE COMPANIES COMPETITIVE ANALYSIS

3.1 World PCR-based Mycoplasma Testing Service Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global PCR-based Mycoplasma Testing Service Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for PCR-based Mycoplasma Testing Service in 2025
  3.2.3 Global Concentration Ratios (CR8) for PCR-based Mycoplasma Testing Service in 2025
3.3 PCR-based Mycoplasma Testing Service Company Evaluation Quadrant
3.4 PCR-based Mycoplasma Testing Service Market: Overall Company Footprint Analysis
  3.4.1 PCR-based Mycoplasma Testing Service Market: Region Footprint
  3.4.2 PCR-based Mycoplasma Testing Service Market: Company Product Type Footprint
  3.4.3 PCR-based Mycoplasma Testing Service Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: PCR-based Mycoplasma Testing Service Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: PCR-based Mycoplasma Testing Service Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
  4.1.2 United States VS China: PCR-based Mycoplasma Testing Service Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: PCR-based Mycoplasma Testing Service Consumption Value Comparison
  4.2.1 United States VS China: PCR-based Mycoplasma Testing Service Consumption Value Comparison (2021 & 2025 & 2032)
  4.2.2 United States VS China: PCR-based Mycoplasma Testing Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based PCR-based Mycoplasma Testing Service Companies and Market Share, 2021-2026
  4.3.1 United States Based PCR-based Mycoplasma Testing Service Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies PCR-based Mycoplasma Testing Service Revenue, (2021-2026)
4.4 China Based Companies PCR-based Mycoplasma Testing Service Revenue and Market Share, 2021-2026
  4.4.1 China Based PCR-based Mycoplasma Testing Service Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies PCR-based Mycoplasma Testing Service Revenue, (2021-2026)
4.5 Rest of World Based PCR-based Mycoplasma Testing Service Companies and Market Share, 2021-2026
  4.5.1 Rest of World Based PCR-based Mycoplasma Testing Service Companies, Headquarters (Province, Country)
  4.5.2 Rest of World Based Companies PCR-based Mycoplasma Testing Service Revenue (2021-2026)

5 MARKET ANALYSIS BY TYPE

5.1 World PCR-based Mycoplasma Testing Service Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
  5.2.1 Product Release Testing
  5.2.2 Contamination Investigation Testing
  5.2.3 Regulatory Compliance Testing
  5.2.4 Others
5.3 Market Segment by Type
  5.3.1 World PCR-based Mycoplasma Testing Service Market Size by Type (2021-2026)
  5.3.2 World PCR-based Mycoplasma Testing Service Market Size by Type (2027-2032)
  5.3.3 World PCR-based Mycoplasma Testing Service Market Size Market Share by Type (2027-2032)

6 MARKET ANALYSIS BY SAMPLE TYPE

6.1 World PCR-based Mycoplasma Testing Service Market Size Overview by Sample Type: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Sample Type
  6.2.1 Cell Bank Testing
  6.2.2 Cell Culture Testing
  6.2.3 Others
6.3 Market Segment by Sample Type
  6.3.1 World PCR-based Mycoplasma Testing Service Market Size by Sample Type (2021-2026)
  6.3.2 World PCR-based Mycoplasma Testing Service Market Size by Sample Type (2027-2032)
  6.3.3 World PCR-based Mycoplasma Testing Service Market Size Market Share by Sample Type (2027-2032)

7 MARKET ANALYSIS BY APPLICATION

7.1 World PCR-based Mycoplasma Testing Service Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
  7.2.1 Biopharmaceutical Companies
  7.2.2 Contract Research/Manufacturing Organizations (CROs/CMOs)
  7.2.3 Universities and Research Institutions
  7.2.4 Others
7.3 Market Segment by Application
  7.3.1 World PCR-based Mycoplasma Testing Service Market Size by Application (2021-2026)
  7.3.2 World PCR-based Mycoplasma Testing Service Market Size by Application (2027-2032)
  7.3.3 World PCR-based Mycoplasma Testing Service Market Size Market Share by Application (2021-2032)

8 COMPANY PROFILES

8.1 Charles River Laboratories International
  8.1.1 Charles River Laboratories International Details
  8.1.2 Charles River Laboratories International Major Business
  8.1.3 Charles River Laboratories International PCR-based Mycoplasma Testing Service Product and Services
  8.1.4 Charles River Laboratories International PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  8.1.5 Charles River Laboratories International Recent Developments/Updates
  8.1.6 Charles River Laboratories International Competitive Strengths & Weaknesses
8.2 Thermo Fisher Scientific
  8.2.1 Thermo Fisher Scientific Details
  8.2.2 Thermo Fisher Scientific Major Business
  8.2.3 Thermo Fisher Scientific PCR-based Mycoplasma Testing Service Product and Services
  8.2.4 Thermo Fisher Scientific PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  8.2.5 Thermo Fisher Scientific Recent Developments/Updates
  8.2.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
8.3 SGS
  8.3.1 SGS Details
  8.3.2 SGS Major Business
  8.3.3 SGS PCR-based Mycoplasma Testing Service Product and Services
  8.3.4 SGS PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  8.3.5 SGS Recent Developments/Updates
  8.3.6 SGS Competitive Strengths & Weaknesses
8.4 Bionique Testing Laboratories
  8.4.1 Bionique Testing Laboratories Details
  8.4.2 Bionique Testing Laboratories Major Business
  8.4.3 Bionique Testing Laboratories PCR-based Mycoplasma Testing Service Product and Services
  8.4.4 Bionique Testing Laboratories PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  8.4.5 Bionique Testing Laboratories Recent Developments/Updates
  8.4.6 Bionique Testing Laboratories Competitive Strengths & Weaknesses
8.5 WuXi AppTec
  8.5.1 WuXi AppTec Details
  8.5.2 WuXi AppTec Major Business
  8.5.3 WuXi AppTec PCR-based Mycoplasma Testing Service Product and Services
  8.5.4 WuXi AppTec PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  8.5.5 WuXi AppTec Recent Developments/Updates
  8.5.6 WuXi AppTec Competitive Strengths & Weaknesses
8.6 Labcorp
  8.6.1 Labcorp Details
  8.6.2 Labcorp Major Business
  8.6.3 Labcorp PCR-based Mycoplasma Testing Service Product and Services
  8.6.4 Labcorp PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  8.6.5 Labcorp Recent Developments/Updates
  8.6.6 Labcorp Competitive Strengths & Weaknesses
8.7 IDEXX BioAnalytics
  8.7.1 IDEXX BioAnalytics Details
  8.7.2 IDEXX BioAnalytics Major Business
  8.7.3 IDEXX BioAnalytics PCR-based Mycoplasma Testing Service Product and Services
  8.7.4 IDEXX BioAnalytics PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  8.7.5 IDEXX BioAnalytics Recent Developments/Updates
  8.7.6 IDEXX BioAnalytics Competitive Strengths & Weaknesses
8.8 WiCell
  8.8.1 WiCell Details
  8.8.2 WiCell Major Business
  8.8.3 WiCell PCR-based Mycoplasma Testing Service Product and Services
  8.8.4 WiCell PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  8.8.5 WiCell Recent Developments/Updates
  8.8.6 WiCell Competitive Strengths & Weaknesses
8.9 Creative Biogene
  8.9.1 Creative Biogene Details
  8.9.2 Creative Biogene Major Business
  8.9.3 Creative Biogene PCR-based Mycoplasma Testing Service Product and Services
  8.9.4 Creative Biogene PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  8.9.5 Creative Biogene Recent Developments/Updates
  8.9.6 Creative Biogene Competitive Strengths & Weaknesses
8.10 Eurofins Scientific
  8.10.1 Eurofins Scientific Details
  8.10.2 Eurofins Scientific Major Business
  8.10.3 Eurofins Scientific PCR-based Mycoplasma Testing Service Product and Services
  8.10.4 Eurofins Scientific PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  8.10.5 Eurofins Scientific Recent Developments/Updates
  8.10.6 Eurofins Scientific Competitive Strengths & Weaknesses
8.11 Hylabs
  8.11.1 Hylabs Details
  8.11.2 Hylabs Major Business
  8.11.3 Hylabs PCR-based Mycoplasma Testing Service Product and Services
  8.11.4 Hylabs PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  8.11.5 Hylabs Recent Developments/Updates
  8.11.6 Hylabs Competitive Strengths & Weaknesses
8.12 JOINN Laboratories
  8.12.1 JOINN Laboratories Details
  8.12.2 JOINN Laboratories Major Business
  8.12.3 JOINN Laboratories PCR-based Mycoplasma Testing Service Product and Services
  8.12.4 JOINN Laboratories PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  8.12.5 JOINN Laboratories Recent Developments/Updates
  8.12.6 JOINN Laboratories Competitive Strengths & Weaknesses
8.13 Shimadzu Diagnostics
  8.13.1 Shimadzu Diagnostics Details
  8.13.2 Shimadzu Diagnostics Major Business
  8.13.3 Shimadzu Diagnostics PCR-based Mycoplasma Testing Service Product and Services
  8.13.4 Shimadzu Diagnostics PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  8.13.5 Shimadzu Diagnostics Recent Developments/Updates
  8.13.6 Shimadzu Diagnostics Competitive Strengths & Weaknesses
8.14 CellSafe
  8.14.1 CellSafe Details
  8.14.2 CellSafe Major Business
  8.14.3 CellSafe PCR-based Mycoplasma Testing Service Product and Services
  8.14.4 CellSafe PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  8.14.5 CellSafe Recent Developments/Updates
  8.14.6 CellSafe Competitive Strengths & Weaknesses
8.15 FullHope Biomedical
  8.15.1 FullHope Biomedical Details
  8.15.2 FullHope Biomedical Major Business
  8.15.3 FullHope Biomedical PCR-based Mycoplasma Testing Service Product and Services
  8.15.4 FullHope Biomedical PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  8.15.5 FullHope Biomedical Recent Developments/Updates
  8.15.6 FullHope Biomedical Competitive Strengths & Weaknesses
8.16 Syngene International
  8.16.1 Syngene International Details
  8.16.2 Syngene International Major Business
  8.16.3 Syngene International PCR-based Mycoplasma Testing Service Product and Services
  8.16.4 Syngene International PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  8.16.5 Syngene International Recent Developments/Updates
  8.16.6 Syngene International Competitive Strengths & Weaknesses
8.17 Beyotime
  8.17.1 Beyotime Details
  8.17.2 Beyotime Major Business
  8.17.3 Beyotime PCR-based Mycoplasma Testing Service Product and Services
  8.17.4 Beyotime PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  8.17.5 Beyotime Recent Developments/Updates
  8.17.6 Beyotime Competitive Strengths & Weaknesses
8.18 CTI Cert
  8.18.1 CTI Cert Details
  8.18.2 CTI Cert Major Business
  8.18.3 CTI Cert PCR-based Mycoplasma Testing Service Product and Services
  8.18.4 CTI Cert PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  8.18.5 CTI Cert Recent Developments/Updates
  8.18.6 CTI Cert Competitive Strengths & Weaknesses
8.19 Shenke Bio
  8.19.1 Shenke Bio Details
  8.19.2 Shenke Bio Major Business
  8.19.3 Shenke Bio PCR-based Mycoplasma Testing Service Product and Services
  8.19.4 Shenke Bio PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  8.19.5 Shenke Bio Recent Developments/Updates
  8.19.6 Shenke Bio Competitive Strengths & Weaknesses

9 INDUSTRY CHAIN ANALYSIS

9.1 PCR-based Mycoplasma Testing Service Industry Chain
9.2 PCR-based Mycoplasma Testing Service Upstream Analysis
9.3 PCR-based Mycoplasma Testing Service Midstream Analysis
9.4 PCR-based Mycoplasma Testing Service Downstream Analysis

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer


LIST OF TABLES

Table 1. World PCR-based Mycoplasma Testing Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World PCR-based Mycoplasma Testing Service Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World PCR-based Mycoplasma Testing Service Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World PCR-based Mycoplasma Testing Service Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World PCR-based Mycoplasma Testing Service Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World PCR-based Mycoplasma Testing Service Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World PCR-based Mycoplasma Testing Service Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World PCR-based Mycoplasma Testing Service Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World PCR-based Mycoplasma Testing Service Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key PCR-based Mycoplasma Testing Service Players in 2025
Table 12. World PCR-based Mycoplasma Testing Service Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global PCR-based Mycoplasma Testing Service Company Evaluation Quadrant
Table 14. Head Office of Key PCR-based Mycoplasma Testing Service Players
Table 15. PCR-based Mycoplasma Testing Service Market: Company Product Type Footprint
Table 16. PCR-based Mycoplasma Testing Service Market: Company Product Application Footprint
Table 17. PCR-based Mycoplasma Testing Service Mergers & Acquisitions Activity
Table 18. United States VS China PCR-based Mycoplasma Testing Service Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China PCR-based Mycoplasma Testing Service Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based PCR-based Mycoplasma Testing Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies PCR-based Mycoplasma Testing Service Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies PCR-based Mycoplasma Testing Service Revenue Market Share (2021-2026)
Table 23. China Based PCR-based Mycoplasma Testing Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies PCR-based Mycoplasma Testing Service Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies PCR-based Mycoplasma Testing Service Revenue Market Share (2021-2026)
Table 26. Rest of World Based PCR-based Mycoplasma Testing Service Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies PCR-based Mycoplasma Testing Service Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies PCR-based Mycoplasma Testing Service Revenue Market Share (2021-2026)
Table 29. World PCR-based Mycoplasma Testing Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World PCR-based Mycoplasma Testing Service Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World PCR-based Mycoplasma Testing Service Market Size by Type (2027-2032) & (USD Million)
Table 32. World PCR-based Mycoplasma Testing Service Market Size by Sample Type, (USD Million), 2021 & 2025 & 2032
Table 33. World PCR-based Mycoplasma Testing Service Market Size Value by Sample Type (2021-2026) & (USD Million)
Table 34. World PCR-based Mycoplasma Testing Service Market Size by Sample Type (2027-2032) & (USD Million)
Table 35. World PCR-based Mycoplasma Testing Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 36. World PCR-based Mycoplasma Testing Service Market Size by Application (2021-2026) & (USD Million)
Table 37. World PCR-based Mycoplasma Testing Service Market Size by Application (2027-2032) & (USD Million)
Table 38. Charles River Laboratories International Basic Information, Manufacturing Base and Competitors
Table 39. Charles River Laboratories International Major Business
Table 40. Charles River Laboratories International PCR-based Mycoplasma Testing Service Product and Services
Table 41. Charles River Laboratories International PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 42. Charles River Laboratories International Recent Developments/Updates
Table 43. Charles River Laboratories International Competitive Strengths & Weaknesses
Table 44. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 45. Thermo Fisher Scientific Major Business
Table 46. Thermo Fisher Scientific PCR-based Mycoplasma Testing Service Product and Services
Table 47. Thermo Fisher Scientific PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. Thermo Fisher Scientific Recent Developments/Updates
Table 49. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 50. SGS Basic Information, Manufacturing Base and Competitors
Table 51. SGS Major Business
Table 52. SGS PCR-based Mycoplasma Testing Service Product and Services
Table 53. SGS PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. SGS Recent Developments/Updates
Table 55. SGS Competitive Strengths & Weaknesses
Table 56. Bionique Testing Laboratories Basic Information, Manufacturing Base and Competitors
Table 57. Bionique Testing Laboratories Major Business
Table 58. Bionique Testing Laboratories PCR-based Mycoplasma Testing Service Product and Services
Table 59. Bionique Testing Laboratories PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. Bionique Testing Laboratories Recent Developments/Updates
Table 61. Bionique Testing Laboratories Competitive Strengths & Weaknesses
Table 62. WuXi AppTec Basic Information, Manufacturing Base and Competitors
Table 63. WuXi AppTec Major Business
Table 64. WuXi AppTec PCR-based Mycoplasma Testing Service Product and Services
Table 65. WuXi AppTec PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. WuXi AppTec Recent Developments/Updates
Table 67. WuXi AppTec Competitive Strengths & Weaknesses
Table 68. Labcorp Basic Information, Manufacturing Base and Competitors
Table 69. Labcorp Major Business
Table 70. Labcorp PCR-based Mycoplasma Testing Service Product and Services
Table 71. Labcorp PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. Labcorp Recent Developments/Updates
Table 73. Labcorp Competitive Strengths & Weaknesses
Table 74. IDEXX BioAnalytics Basic Information, Manufacturing Base and Competitors
Table 75. IDEXX BioAnalytics Major Business
Table 76. IDEXX BioAnalytics PCR-based Mycoplasma Testing Service Product and Services
Table 77. IDEXX BioAnalytics PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. IDEXX BioAnalytics Recent Developments/Updates
Table 79. IDEXX BioAnalytics Competitive Strengths & Weaknesses
Table 80. WiCell Basic Information, Manufacturing Base and Competitors
Table 81. WiCell Major Business
Table 82. WiCell PCR-based Mycoplasma Testing Service Product and Services
Table 83. WiCell PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. WiCell Recent Developments/Updates
Table 85. WiCell Competitive Strengths & Weaknesses
Table 86. Creative Biogene Basic Information, Manufacturing Base and Competitors
Table 87. Creative Biogene Major Business
Table 88. Creative Biogene PCR-based Mycoplasma Testing Service Product and Services
Table 89. Creative Biogene PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. Creative Biogene Recent Developments/Updates
Table 91. Creative Biogene Competitive Strengths & Weaknesses
Table 92. Eurofins Scientific Basic Information, Manufacturing Base and Competitors
Table 93. Eurofins Scientific Major Business
Table 94. Eurofins Scientific PCR-based Mycoplasma Testing Service Product and Services
Table 95. Eurofins Scientific PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. Eurofins Scientific Recent Developments/Updates
Table 97. Eurofins Scientific Competitive Strengths & Weaknesses
Table 98. Hylabs Basic Information, Manufacturing Base and Competitors
Table 99. Hylabs Major Business
Table 100. Hylabs PCR-based Mycoplasma Testing Service Product and Services
Table 101. Hylabs PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. Hylabs Recent Developments/Updates
Table 103. Hylabs Competitive Strengths & Weaknesses
Table 104. JOINN Laboratories Basic Information, Manufacturing Base and Competitors
Table 105. JOINN Laboratories Major Business
Table 106. JOINN Laboratories PCR-based Mycoplasma Testing Service Product and Services
Table 107. JOINN Laboratories PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 108. JOINN Laboratories Recent Developments/Updates
Table 109. JOINN Laboratories Competitive Strengths & Weaknesses
Table 110. Shimadzu Diagnostics Basic Information, Manufacturing Base and Competitors
Table 111. Shimadzu Diagnostics Major Business
Table 112. Shimadzu Diagnostics PCR-based Mycoplasma Testing Service Product and Services
Table 113. Shimadzu Diagnostics PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 114. Shimadzu Diagnostics Recent Developments/Updates
Table 115. Shimadzu Diagnostics Competitive Strengths & Weaknesses
Table 116. CellSafe Basic Information, Manufacturing Base and Competitors
Table 117. CellSafe Major Business
Table 118. CellSafe PCR-based Mycoplasma Testing Service Product and Services
Table 119. CellSafe PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 120. CellSafe Recent Developments/Updates
Table 121. CellSafe Competitive Strengths & Weaknesses
Table 122. FullHope Biomedical Basic Information, Manufacturing Base and Competitors
Table 123. FullHope Biomedical Major Business
Table 124. FullHope Biomedical PCR-based Mycoplasma Testing Service Product and Services
Table 125. FullHope Biomedical PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 126. FullHope Biomedical Recent Developments/Updates
Table 127. FullHope Biomedical Competitive Strengths & Weaknesses
Table 128. Syngene International Basic Information, Manufacturing Base and Competitors
Table 129. Syngene International Major Business
Table 130. Syngene International PCR-based Mycoplasma Testing Service Product and Services
Table 131. Syngene International PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 132. Syngene International Recent Developments/Updates
Table 133. Syngene International Competitive Strengths & Weaknesses
Table 134. Beyotime Basic Information, Manufacturing Base and Competitors
Table 135. Beyotime Major Business
Table 136. Beyotime PCR-based Mycoplasma Testing Service Product and Services
Table 137. Beyotime PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 138. Beyotime Recent Developments/Updates
Table 139. Beyotime Competitive Strengths & Weaknesses
Table 140. CTI Cert Basic Information, Manufacturing Base and Competitors
Table 141. CTI Cert Major Business
Table 142. CTI Cert PCR-based Mycoplasma Testing Service Product and Services
Table 143. CTI Cert PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 144. CTI Cert Recent Developments/Updates
Table 145. CTI Cert Competitive Strengths & Weaknesses
Table 146. Shenke Bio Basic Information, Manufacturing Base and Competitors
Table 147. Shenke Bio Major Business
Table 148. Shenke Bio PCR-based Mycoplasma Testing Service Product and Services
Table 149. Shenke Bio PCR-based Mycoplasma Testing Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 150. Shenke Bio Recent Developments/Updates
Table 151. Shenke Bio Competitive Strengths & Weaknesses
Table 152. Global Key Players of PCR-based Mycoplasma Testing Service Upstream (Raw Materials)
Table 153. Global PCR-based Mycoplasma Testing Service Typical Customers

LIST OF FIGURES

Figure 1. PCR-based Mycoplasma Testing Service Picture
Figure 2. World PCR-based Mycoplasma Testing Service Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World PCR-based Mycoplasma Testing Service Total Revenue (2021-2032) & (USD Million)
Figure 4. World PCR-based Mycoplasma Testing Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World PCR-based Mycoplasma Testing Service Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company PCR-based Mycoplasma Testing Service Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company PCR-based Mycoplasma Testing Service Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company PCR-based Mycoplasma Testing Service Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company PCR-based Mycoplasma Testing Service Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company PCR-based Mycoplasma Testing Service Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company PCR-based Mycoplasma Testing Service Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company PCR-based Mycoplasma Testing Service Revenue (2021-2032) & (USD Million)
Figure 13. PCR-based Mycoplasma Testing Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World PCR-based Mycoplasma Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 16. World PCR-based Mycoplasma Testing Service Consumption Value Market Share by Region (2021-2032)
Figure 17. United States PCR-based Mycoplasma Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 18. China PCR-based Mycoplasma Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe PCR-based Mycoplasma Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan PCR-based Mycoplasma Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea PCR-based Mycoplasma Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN PCR-based Mycoplasma Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 23. India PCR-based Mycoplasma Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of PCR-based Mycoplasma Testing Service by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for PCR-based Mycoplasma Testing Service Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for PCR-based Mycoplasma Testing Service Markets in 2025
Figure 27. United States VS China: PCR-based Mycoplasma Testing Service Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: PCR-based Mycoplasma Testing Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World PCR-based Mycoplasma Testing Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World PCR-based Mycoplasma Testing Service Market Size Market Share by Type in 2025
Figure 31. Product Release Testing
Figure 32. Contamination Investigation Testing
Figure 33. Regulatory Compliance Testing
Figure 34. Others
Figure 35. World PCR-based Mycoplasma Testing Service Market Size Market Share by Type (2021-2032)
Figure 36. World PCR-based Mycoplasma Testing Service Market Size by Sample Type, (USD Million), 2021 & 2025 & 2032
Figure 37. World PCR-based Mycoplasma Testing Service Market Size Market Share by Sample Type in 2025
Figure 38. Cell Bank Testing
Figure 39. Cell Culture Testing
Figure 40. Others
Figure 41. World PCR-based Mycoplasma Testing Service Market Size Market Share by Sample Type (2021-2032)
Figure 42. World PCR-based Mycoplasma Testing Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 43. World PCR-based Mycoplasma Testing Service Market Size Market Share by Application in 2025
Figure 44. Biopharmaceutical Companies
Figure 45. Contract Research/Manufacturing Organizations (CROs/CMOs)
Figure 46. Universities and Research Institutions
Figure 47. Others
Figure 48. World PCR-based Mycoplasma Testing Service Market Size Market Share by Application (2021-2032)
Figure 49. PCR-based Mycoplasma Testing Service Industrial Chain
Figure 50. Methodology
Figure 51. Research Process and Data Source


More Publications